This post is by Russ Garland from Venture Capital Dispatch
Click here to view on the original site: Original Post
Medical venture capitalists are taking aim at many of the most common and complex diseases, investing more than $1 billion each last year into treatments for conditions affecting the brain, heart, pancreas and immune system. It was the first time investment in four body systems crossed that threshold in a year, according to an analysis of health-care venture investment across 17 categories by VentureWire and Dow Jones VentureSource. All told, six fields drew record funding: blood, brain, muscles, pancreas, and the immune and reproductive systems.
ALSO IN TODAY’S VENTUREWIRE (subscription required):
HungryRoot Inc., a startup peddling pasta made from vegetables and other healthy stand-ins for a foodie’s indulgences, has raised $3.7 million in a Series A round led by Lightspeed Venture Partners.
Rocksbox Inc., which sends monthly subscription boxes of jewelry to raised $8.7 million in Series A funds.
Chromis Therapeutics Inc. has secured $3 million in seed financing to advance curative treatments for chronic hepatitis B infection, a condition that greatly increases risk for liver cancer.
YourMechanic Services Inc. has raised $24 million in a Series B round of funding for its app that lets people book house calls from certified auto-mechanics.
Mariana Technology Inc., a “demand generation” platform that uses artificial intelligence for business-to-business marketing, has raised $2 million in convertible notes, in a round led by Blumberg Capital that will close in March.
(VentureWire is a daily newsletter with comprehensive analysis of all the investments, deals and personnel moves involving startups and their venture backers. For a two-week trial, visit http://on.wsj.com/DJPEVCNews, scroll to the bottom and click “try for free.”)
Write to Russ Garland at email@example.com